All In Biotech

Drug Trial Radar · NCT03569007

Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms

A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of Persistent Symptoms in Patients With Celiac Disease on a GFD

Last checked: Nov 19, 2026Latest source record: Jul 26, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. Randomized with 307 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

307

Actual

Start

May 29, 2019

Primary completion

Jul 21, 2022

Study completion Jul 21, 2022

Sponsor

Lead sponsor
9 Meters Biopharma, Inc.Industry
Sponsor type
Industry
First posted
Jun 26, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To assess the efficacy and safety of larazotide acetate versus placebo for the relief of persistent symptoms in adult celiac disease patients.

Conditions

  • Celiac Disease

Interventions

  • LarazotideDrug

    Synthetic 8-amino acid peptide formulated as enteric-coated beads in gelatin capsules

  • Matching PlaceboDrug

    enteric-coated beads in gelatin capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of subjects who are binary respondersTime frame: 12 weeks

Locations

160 sites in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Saraland, Alabama

  • Research Site

    Scottsdale, Arizona

  • Research Site

    Tucson, Arizona

  • Research Site

    Tucson, Arizona

  • Research Site

    North Little Rock, Arkansas

  • Research Site

    Bellflower, California

  • Research Site

    Beverly Hills, California

  • Research Site

    Canoga Park, California

  • Research Site

    Corona, California

  • Research Site

    Garden Grove, California

  • Research Site

    Lancaster, California

  • Research Site

    Los Gatos, California

  • Research Site

    Northridge, California

  • Research Site

    Poway, California

  • Research Site

    Rialto, California

  • Research Site

    San Diego, California

  • Research Site

    San Diego, California

  • Research Site

    San Francisco, California

  • Research Site

    Walnut Creek, California

  • Research Site

    Bridgeport, Connecticut

  • Research Site

    Bristol, Connecticut

  • Research Site

    Hamden, Connecticut

  • Research Site

    Stamford, Connecticut

  • Research Site

    Boynton Beach, Florida

  • Research Site

    Clearwater, Florida

  • Research Site

    Inverness, Florida

  • Research Site

    Lakewood Rch, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Orange Park, Florida

  • Research Site

    Orlando, Florida

  • Research Site

    Orlando, Florida

  • Research Site

    Port Orange, Florida

  • Research Site

    Atlanta, Georgia

  • Research Site

    Columbus, Georgia

  • Research Site

    Macon, Georgia

  • Research Site

    Stockbridge, Georgia

  • Research Site

    Stone Mountain, Georgia

  • Research Site

    Sugar Hill, Georgia

  • Research Site

    Boise, Idaho

  • Research Site

    Idaho Falls, Idaho

Showing 40 of 160 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.